Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2021

01-12-2021 | Colorectal Cancer | Review

Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms

Author: Zhiliang Chen

Published in: Cancer Cell International | Issue 1/2021

Login to get access

Abstract

Relevance

Pien Tze Huang (PZH) is a well-known Traditional Chinese Medicine (TCM), characterized by a multitude of pharmacological effects, such as hepatoprotection and inhibition of inflammation and cell proliferative conditions. Many of these effects have been validated at the cellular, molecular and physiological levels but, to date, most of these findings have not been comprehensively disclosed.

Objectives

This review aims to provide a critical summary of recent studies focusing on PZH and its multiple pharmacological effects. As a result, we further discuss some novel perspectives related to PZH’s mechanisms of action and a holistic view of its therapeutic activities.

Methods

A systematic review was performed focusing on PZH studies originated from original scientific resources. The scientific literature retrieved for this work was obtained from International repositories including NCBI/PubMed, Web of Science, Science Direct and China National Knowledge Infrastructure (CNKI) databases.

Results

The major active componentes and their potential functions, including hepatoprotective and neuroprotective effects, as well as anti-cancer and anti-inflammatory activities, were summarized and categorized accordingly. As indicated, most of the pharmacological effects were validated in vitro and in vivo. The identification of complex bioactive components in PZH may provide the basis for further therapeutic initiatives.

Conclusion

Here we have collectively discussed the recent evidences covering most, if not all, pharmacological effects driven by PZH. This review provides novel perspectives on understanding the modes of action and the holistic view of TCM. The rational development of future clinical trials will certainly provide evidence-based medical evidences that will also confirm the therapeutic advantages of PZH, based on the current information available.
Literature
1.
Hong F, Chen Z, Tang HC, Wu SL, Yang J, Yew DT. Herbal medicine for liver protection in experimental animals-a histochemical, pathological study.
2.
3.
4.
Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen M, et al. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol. 2013;149:601–12.PubMedCrossRef
5.
Nikakhlagh S, Rahim F, Aryani FHN, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol Head Neck Med Surg. 2011;32:402–7.
6.
7.
8.
9.
Meshram Y, Ray SK. Epigenetics and cancer. Drug Invent Today|. 2019;12:265–8.
10.
Nie J, Zhao C, Deng L, Chen J, Yu B, Wu X, et al. Efficacy of traditional Chinese medicine in treating cancer (Review). Biomed Reports. 2016;4:3–14.CrossRef
11.
Lu AP, Jia HW, Xiao C, Lu QP. Theory of traditional Chinese medicine and therapeutic method of diseases. World J. Gastroenterol. [Internet]. WJG Press; 2004;10:1854–6. /pmc/articles/PMC4572216/?report=abstract. Accessed 22 Nov 2020.
12.
13.
Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis. Chongqing University; 2019.
14.
Lin W fu, Lu J ying, Cheng B bin, Ling C quan. Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment. J Integr Med. Elsevier (Singapore) Pte Ltd; 2017. p. 282–7.
15.
Yang J, Pi C, Wang G. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed Pharmacother Elsevier Masson SAS. 2018;103:699–707.CrossRef
16.
Zheng H, Wang X, Zhang Y, Chen L, Hua L, Xu W. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis. J Ethnopharmacol. 2019;244:111856.PubMedCrossRef
17.
18.
Xu W, Zhang Y, Zhou C, Tai Y, Zhang X, Liu J, et al. Simultaneous quantification six active compounds in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study of Pien-Tze-Huang. J. Chromatogr B Anal Technol Biomed Life Sci 2017;1061–1062:314–21.
19.
Huang L, Zhang Y, Zhang X, Chen X, Wang Y, Lu J, et al. Therapeutic potential of Pien-tze-huang: a review on its chemical composition, pharmacology, and clinical application. Molecules [Internet]. MDPI AG; 2019. /pmc/articles/PMC6767116/?report=abstract. Accessed 26 Dec 2020.
20.
Dong TTX, Cui XM, Song ZH, Zhao KJ, Ji ZN, Lo CK, et al. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem. 2003;51:4617–23.PubMedCrossRef
21.
Xie GX, Qiu YP, Qiu MF, Gao XF, Liu YM, Jia W. Analysis of dencichine in Panax notoginseng by gas chromatography-mass spectrometry with ethyl chloroformate derivatization. J Pharm Biomed Anal. 2007;43:920–5.PubMedCrossRef
22.
Wang Z, Yang JY, Song SJ, Zhao SHWY. Effect of dencichine on coagulation and the hemostatic mechanism. Chinese J New Drugs. 2014;23:356–9.
23.
Gao BY, Li XJ, Liu L. Zhang BH [Effect of panaxatriol saponins isolated from Panax notoginseng (PTS) on myocardial ischemic arrhythmia in mice and rats]. Yao Xue Xue Bao. 1992;27:641–4.PubMed
24.
Xia W, Sun C, Zhao Y, Wu L. Hypolipidemic and antioxidant activities of Sanchi (Radix Notoginseng) in rats fed with a high fat diet. Phytomedicine. 2011;18:516–20.PubMedCrossRef
25.
Hai-shan Y, Information JC-S& T, 2010 U. An overview of pharmacological effects of panax notoginseng on blood, cardio-cerebrovascular and central nervous system. en.cnki.com.cn.
26.
Sun H, Yang Z, Ye Y. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng. Int Immunopharmacol. 2006;6:14–25.PubMedCrossRef
27.
Yi-ling W, Di CJW. Effects and mechanism of total saponins of panax notoginseng on anti-inflammation and analgesia. Chin J Integr Tradit West Med. 1994;2:90–90.
28.
Yeh Y-H, Wang D-Y, Liau M-Y, Wu M-L, Deng J-F, Noguchi T, et al. Bile acid composition in snake bile juice and toxicity of snake bile acids to rats. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136:277–84.PubMedCrossRef
29.
30.
31.
32.
Hai-feng, Tang, Zhou Wei ZW. Snake gall pharmacological study and clinical application of exploration to [J]. J Pract Tradit Chinese Intern Med 2009;
33.
Zou QW, Shi Y, Wei F, Lin RC, Ma SC. Study on chemical composition and pharmacological effects of Bovis Calculus medicinal materials. Chin Pharm Aff. 2014;28:646–50.
34.
Wan TC, Cheng FY, Liu YT, Lin LC, Sakata R. Study on bioactive compounds of in vitro cultured Calculus Suis and natural Calculus Bovis. Anim Sci J. 2009;80:697–704.PubMedCrossRef
35.
Shumin G, Yansheng S, Rujuan W. A comparative study on antipyretic and sedative actions of cow teeth root with bezoar and artificial bezoar. Chin Tradit Herb Drugs. 1996;27:603–5.
36.
Shin SK, Lee YB, Shin DJ, Park HM, Park KH, Seong YH, Kim JH, Lim EK, Park CW. Correlation of serum total bilirubin levels and the severity of acute ischemic stroke. Korean J Cerebrovasc Surg. 2008;10:442–7.
37.
Mas MR, Comert B, Mas N, Yamanel L, Ozotuk H, Tasci I, et al. Effects of long term hydrophilic bile acid therapy on in vitro containing of gallbladder muscle strips in patients with cholesterol gallstones. World J Gastroenterol WJG Press. 2007;13:4336–9.CrossRef
38.
He W, Xu Y, Zhang C, Lu J, Li J, Xiang D, et al. Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes. Drug Des Devel Ther. 2017;11:3449–60.PubMedPubMedCentralCrossRef
39.
Li T, Yang Z, Cai HJ, Song LW, Lu KY, Zhou Z, et al. Effects of in vitro cultivated Calculus Bovis compound on pulmonary lesions in rabbits with schistosomiasis. World J Gastroenterol. 2010;16:749–54.PubMedPubMedCentralCrossRef
40.
Jin R, Zhang B, Xue CM, Liu SM, Zhao Q, Li K. Classification of 365 Chinese medicines in Shennong’s Materia Medica Classic based on a semi-supervised incremental clustering method. J Chinese Integr Med. 2011;9:665–74.CrossRef
41.
Lin J, Feng J, Jin Y, Yan Z, Lai Z, Peng J. Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer. Oncol Rep. 2016;36:3568–76.PubMedCrossRef
42.
Tan H. Comparison on some pharmacological actions of musks from wild and domestic male musk deer in mice. Chin J Pharm Anal. 1993;13:223–8.
43.
Chen YS. Comparative studies on the pharmacological activities of muskrat and musk. Zhong yao tong bao. 1988;13:46.PubMed
44.
Chen YS, Jin SD, Dong WC, Tong YR, Hua SF, Zhao HY. Effect of muskrat on the cardiovascular system in anesthetized dogs. Zhongguo Zhong Yao Za Zhi. 1989;14(241–3):256.
45.
Ye RY. Effect of heart-protecting Musk Pill on cardiac function of ischemic heart disease. Zhejiang J Integr Tradit. 2006;16:734–5.
46.
Hyun E, Bolla M, Steinhoff M, Wallace JL, Del Soldato P, Vergnolle N. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol. 2004;143:618–25.PubMedPubMedCentralCrossRef
47.
Shi J-F, Zhang B-A, Jia Y-J. Protective effect of musk extract on rat’s cerebral cortical neurons with inflammatory injury. Chin J Integr Tradit West Med. 2010;30:625–9.
48.
Xu L, Cao Y. Native musk and synthetic musk ketone strongly induced the growth repression and the apoptosis of cancer cells. BMC Complement Altern Med. 2016;16:511.PubMedPubMedCentralCrossRef
49.
Yu L, Cong R, Lin S, Sun Z, Li H, Lin P, Chu KXW. Determination of active components in Pien Tze Huang by mixed micellar electrokinetic chromatography. J Anal Sci. 2015.
50.
Lai YJ, Chen JPYY. Determination of four compounds in Pien Tze Huang by HPLC. Chinese Pharm J. 2008.
51.
Huang M, Zhao H, Xu W, Chu K, Hong Z, Peng J, et al. Rapid simultaneous determination of twelve major components in Pien Tze Huang by ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry. J Sep Sci. 2013;36:3866–73.PubMedCrossRef
52.
Huang M, Xu W, Zhang Y, Liu J, Zhang X, Lin J, et al. Identification and quantification of the anti-inflammatory constituents in Pian-Tze-Huang by liquid chromatography combined with quadrupole time-of-flight and triple quadrupole mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1027:27–39.CrossRef
53.
Hou YL, Tsai YH, Lin YH, Chao JCJ. Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats. BMC Complement Altern Med. 2014;14:415.PubMedPubMedCentralCrossRef
54.
Park S, Ahn IS, Kwon DY, Ko BS, Jun WK. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance β-cell insulin secretion and viability in min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem. 2008;72:2815–23.PubMedCrossRef
55.
Lee KKH, Kwong WH, Chau FT, Yew DT, Chan WY. Pien Tze Huang protects the liver against carbon tetrachloride-induced damage. Pharmacol Toxicol. 2002;91:185–92.PubMedCrossRef
56.
Yang Y, Chen Z, Deng L, Yu J, Wang K, Zhang X, et al. Pien Tze Huang ameliorates liver injury by inhibiting the PERK/eIF2α signaling pathway in alcohol and high-fat diet rats. Acta Histochem Elsevier GmbH. 2018;120:578–85.CrossRef
57.
Chan WY, Chau FT, Lee KKH, Kwong WH, Yew DT. Substitution for natural musk in Pien Tze Huang does not affect its hepatoprotective activities. Hum Exp Toxicol Arnold. 2004;23:35–47.CrossRef
58.
Zhao J, Zhang Y, Wan Y, Hu H, Hong Z. Pien Tze Huang Gan Bao attenuates carbon tetrachloride-induced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress. Mol Med Rep. 2017;16:2611–9.PubMedPubMedCentralCrossRef
59.
Zhao J, Hu H, Wan Y, Zhang Y, Zheng L, Hong Z. Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats. spandidos-publications.com.
60.
Lyu-yu D, Feng-hua L, Guang J, Yan-chun C, Xing Z, Technology EC for S and, et al. Effect Study of Pien Tze Huang on nonalcoholic fatty liver disease in rats. Chin J Exp Tradit. Med Formulae. 2015;124–8.
61.
Schwarz DS, Blower MD. The endoplasmic reticulum: Structure, function and response to cellular signaling. Cell Mol Life Sci 2016. p. 79–94.
62.
Guoli L, Hongshan W, Jianping Z, Fan X, Junyan H, Zhiying L, et al. The protection of panax notoginseng saponins against liver damage and its potential mechanisms. Chin J Exp Clin Infect Dis Version. 2007;1:5–9.
63.
Ding RB, Tian K, Cao YW, Bao JL, Wang M, He C, et al. Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress. J Agric Food Chem. 2015;63:2413–22.PubMedCrossRef
64.
Wang DD, Zhu HZ, Li SW, Yang JM, Xiao Y, Kang QR, et al. Crude saponins of Panax notoginseng have neuroprotective effects to inhibit palmitate-triggered endoplasmic reticulum stress-associated apoptosis and loss of postsynaptic proteins in staurosporine differentiated RGC-5 retinal ganglion cells. J Agric Food Chem. 2016;64:1528–39.PubMedCrossRef
65.
Wang LC, Zhang WS, Liu Q, Li J, Alolga RN, Liu K, et al. A standardized notoginseng extract exerts cardioprotection by attenuating apoptosis under endoplasmic reticulum stress conditions. J Funct Foods Elsevier Ltd. 2015;16:20–7.CrossRef
66.
Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxidants Redox Signal. 2014. p. 460–73.
67.
Costas MA, Rubio MF. Autophagy. A strategy for cell survival. Medicina. 2017;77:314–20.PubMed
68.
69.
Próchnicki T, Latz E. Inflammasomes on the crossroads of innate immune recognition and metabolic control. Cell Metab. 2017;26:71–93.PubMedCrossRef
70.
Kim SH, Son KM, Kim KY, Yu SN, Park SG, Kim YW, et al. Deoxypodophyllotoxin induces cytoprotective autophagy against apoptosis via inhibition of PI3K/AKT/mTOR pathway in osteosarcoma U2OS cells. Pharmacol Rep. 2017;69:878–84.PubMedCrossRef
71.
Bing-yi C, Wen-tao G, Jia-hui L, Nan L, Yan Z, Traumatology S of O and, et al. Pien Tze Huang inhibited proliferation of human osteosarcoma drug resistant cells MG63/ADM via PI3K/Akt pathway. China J Tradit Chin Med Pharm 2017;1520–4.
72.
Peng R, Wang S, Wang R, Wang Y, Wu Y, Yuan Y. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways. Discov Med. 2017;23:81–94.PubMed
73.
Gao H, Sun Y, Yu HT, Zhang CJ. Mechanism of ginsenoside Rh2 inhibit non-small cell lung cancer. Adv Mater Res. 2013;749:167–71.CrossRef
74.
Qiu X, Guo Q, Liu X, Luo H, Fan D, Deng Y, et al. Pien Tze Huang alleviates relapsing-remitting experimental autoimmune encephalomyelitis mice by regulating Th1 and Th17 cells. Front Pharmacol. 2018;9:1237.PubMedPubMedCentralCrossRef
75.
76.
Zhang L, Lam WP, Lü L, Wang C, Wong YW, Lam LH, et al. Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke. Chin Med. 2010;5:1–4.PubMedPubMedCentralCrossRef
77.
Zhang X, Zhang Y, Tang S, Yu L, Zhao Y, Ren Q, et al. Pien-Tze-Huang protects cerebral ischemic injury by inhibiting neuronal apoptosis in acute ischemic stroke rats. J Ethnopharmacol Elsevier Ireland Ltd. 2018;219:117–25.CrossRef
78.
Lu L, Wai MSM, Yew DT, Mak YT. Pien Tze Huang, a composite Chinese traditional herbal extract, affects survival of neuroblastoma cells. Int J Neurosci. 2009;119:255–62.PubMedCrossRef
79.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140:527–46.PubMed
80.
Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164:1079–106.PubMedPubMedCentralCrossRef
81.
Lee MJ, Jang M, Choi J, Chang BS, Kim DY, Kim SH, et al. Korean red ginseng and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Mol Neurobiol. 2016;53:1977–2002.PubMedCrossRef
82.
Qian L, Xiyan H, Lingqun Z. Effect of Pien Tze Huang on aquaporin-4 express in focal cerebral infarction rats. Chin J Integr Med Cardio/cerebrovasc Dis. 2013;11:59–61.
83.
Zhang L, Lam WP, Lu L, Wang Y-XJ, Wong YW, Lam LH, et al. How would composite traditional chinese medicine protect the brain—an example of the composite formula “Pien Tze Huang”. Curr Med Chem 2011;18:3590–4.
84.
Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749–68.PubMedPubMedCentralCrossRef
85.
Rezaee Z, Yadollahpour A, Bayati V, Dehbashi FN. Gold nanoparticles and electroporation impose both separate and synergistic radiosensitizing effects in HT-29 tumor cells: an in vitro study. Int J Nanomed. 2017;12:1431–9.CrossRef
86.
Yadollahpour A, Rezaee Z, Bayati V, Birgani MJT, Dehbashi FN. Radiotherapy enhancement with electroporation in human intestinal colon cancer HT-29 Cells. Asian Pacific J Cancer Prev. 2018;19:1259–62.
87.
88.
Wu P, Zhu H, Zhuang Y, Sun X, Gu N. Combined therapeutic effects of131I-Labeled and 5Fu-loaded multifunctional nanoparticles in colorectal cancer. Int J Nanomed. 2020;15:2777–87.CrossRef
89.
Rezaee Z, Yadollahpour A, Bayati V. Single intense microsecond electric pulse induces radiosensitization to ionizing radiation: effects of time intervals between electric pulse and ionizing irradiation. Front Oncol. 2018;8:418.PubMedPubMedCentralCrossRef
90.
Edlich F. BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun. 2018;500:26–34.PubMedCrossRef
91.
Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JSC. Pim kinases phosphorylate multiple sites in Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol. 2006;7:1–4.PubMedPubMedCentralCrossRef
92.
Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014;17:471–94.PubMedPubMedCentralCrossRef
93.
94.
Zhuang Q, Hong F, Shen A, Zheng L, Zeng J, Lin W, et al. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model. Int J Oncol. 2012;40:1569–74.PubMed
95.
Lin JM, Wei LH, Chen YQ, Liu XX, Hong ZF, Sferra TJ, et al. Pien Tze Huang-induced apoptosis in human colon cancer HT-29 cells is associated with regulation of the Bcl-2 family and activation of caspase 3. Chin J Integr Med. 2011;17:685–90.PubMedCrossRef
96.
Shen A, Hong F, Liu L, Lin J, Zhuang Q, Hong Z, et al. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro. Chin J Integr Med. 2012;18:431–6.PubMedCrossRef
97.
Ren S, Yuan F, Liu Y, Zhou L, Li J. Effect of p27 gene combined with Pientzehuang (片仔癀) on tumor growth in osteosarcoma-bearing nude mice. Chin J Integr Med. 2015;21:830–6.PubMedCrossRef
98.
99.
Wan Y, Shen A, Qi F, Chu J, Cai Q, Sferra TJ, et al. Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p. Exp Ther Med. 2017;14:3901–7.PubMedPubMedCentralCrossRef
100.
Fu C, Chu J, Shen A, Liu L, Chen H, Lin J, et al. Pien Tze Huang alleviates 5-fluorouracil-induced intestinal mucositis in CT-26 tumor-bearing mice. Exp Ther Med. 2017;14:2291–7.PubMedPubMedCentralCrossRef
101.
Shen A, Lin J, Chen Y, Lin W, Liu L, Hong Z, et al. Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways. Oncol Rep. 2013;30:1701–6.PubMedCrossRef
102.
Mohamed SY, Mohammed HL, Ibrahim HM, Mohamed EM, Salah M. Role of VEGF, CD105, and CD31 in the prognosis of colorectal cancer cases. J Gastrointest Cancer. 2019;50:23–34.PubMedCrossRef
103.
104.
Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q, et al. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Int J Oncol. 2015;46:685–90.PubMedCrossRef
105.
Lin W, Zhuang Q, Zheng L, Cao Z, Shen A, Li Q, et al. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer. Oncol Rep. 2015;33:1922–8.PubMedCrossRef
106.
Pan Y, Liang H, Chen W, Zhang H, Wang N, Wang F, et al. MicroRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. RNA Biol. 2015;12:276–89.PubMedPubMedCentralCrossRef
107.
Fu Y, Zhang L, Hong Z, Zheng H, Li N, Gao H, et al. Methanolic extract of pien tze huang induces apoptosis signaling in human osteosarcoma MG63 cells via multiple pathways. Molecules. 2016;21:283.PubMedPubMedCentralCrossRef
108.
He F, Wu HN, Cai MY, Li CP, Zhang X, Wan Q, et al. Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway. Oncol Lett. 2014;7:2047–52.PubMedPubMedCentralCrossRef
109.
Wei L, Chen P, Chen Y, Shen A, Chen H, Lin W, et al. Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells. Mol Med Rep. 2014;9:261–6.PubMedCrossRef
110.
Qi F, Wei L, Shen A, Chen Y, Lin J, Chu J, et al. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway. Oncol Rep. 2016;35:511–7.PubMedCrossRef
111.
112.
Zhang Y, Wang Q, Niu S, Liu J, Zhang L. Pien Tze Huang induces apoptosis in multidrug-resistant U2OS/ADM cells via downregulation of Bcl-2, survivin and P-gp and upregulation of Bax. Oncol Rep. 2014;31:763–70.PubMedCrossRef
113.
Qi F, Zhou S, Li L, Wei L, Shen A, Liu L, et al. Pien Tze Huang inhibits the growth of hepatocellular carcinoma cells by upregulating miR-16 expression. Oncol Lett. 2017;14:8132–7.PubMedPubMedCentral
114.
Chen X, Qi F, Shen AL, Chu JF, Sferra TJ, Chen YQ, et al. Pien Tze Huang (片仔癀) overcomes doxorubicin resistance and inhibits epithelial-mesenchymal transition in MCF-7/ADR CELLS. Chin J Integr Med. 2019;25:598–603.PubMedCrossRef
115.
116.
Chen H, Shen A, Zhang Y, Chen Y, Lin J, Lin W, et al. Pien Tze Huang inhibits hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells through suppression of the HIF-1 pathway. Exp Ther Med. 2014;7:1237–42.PubMedPubMedCentralCrossRef
117.
Shackleton M. Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol. 2010;20:85–92.PubMedCrossRef
118.
Li L, Shen A, Chu J, Sferra TJ, Sankararaman S, Ke X, et al. Pien Tze Huang ameliorates DSS-induced colonic inflammation in a mouse colitis model through inhibition of the IL-6/STAT3 pathway. Mol Med Rep. 2018;18:1113–9.PubMed
Metadata
Title
Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms
Author
Zhiliang Chen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-021-01785-3

Other articles of this Issue 1/2021

Cancer Cell International 1/2021 Go to the issue

Primary research

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma

Primary research

miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in Hedgehog pathway

Primary research

Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9

Primary research

CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p

Review

Mitochondrial pyruvate carrier 1: a novel prognostic biomarker that predicts favourable patient survival in cancer

Primary research

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits